SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) was the recipient of unusually large options trading activity on Friday. Investors bought 73,593 put options on the company. This represents an increase of 25% compared to the typical volume of 58,703 put options.
Hedge Funds Weigh In On SPDR S&P Biotech ETF
Several large investors have recently made changes to their positions in the business. Tidemark LLC lifted its position in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at about $40,000. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth about $40,000. ORG Wealth Partners LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter worth about $44,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF in the third quarter worth about $49,000.
SPDR S&P Biotech ETF Trading Down 1.4 %
NYSEARCA XBI traded down $1.31 during trading hours on Friday, hitting $92.89. 7,753,218 shares of the company’s stock traded hands, compared to its average volume of 9,413,228. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The firm has a market capitalization of $7.08 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s fifty day moving average price is $98.13 and its two-hundred day moving average price is $96.98.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What Are Growth Stocks and Investing in Them
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Why Invest in High-Yield Dividend Stocks?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
- Breakout Stocks: What They Are and How to Identify Them
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.